Consideration of antibody production of a COMIRNATY intramuscular injection

Consideration of antibody production of a COMIRNATY intramuscular injection - COMIRNATY

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044261

Enrollment

551

Registered

2021-06-07

Start date

2021-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) the staff who took inoculation of a COMIRNATY intramuscular injection in Kamagaya general hospital (I don't ask about the number of times.) 2) the way where the age of the time of the agreement merit is more than 20 years old (I don't ask about the gender.) 3) the back and the way where documentary consent by free will of the patient person himself was got where I had the enough explanation in case of participation of this research

Exclusion criteria

Exclusion criteria: The person who judged that a study person in charge was unsuitable as a subject of research person

Design outcomes

Primary

Measure	Time frame
The antibody positive rate which is 3 months after COMIRNATY intramuscular injection	—

Countries

Japan

Contacts

Public ContactTakeshi Mochizuki

Kamagaya General Hospital Plastic surgery

chiken@kamagaya-hp.jp047-498-8266

Outcome results